Commonwealth Consolidated Regulations Commonwealth Consolidated Regulations(1) Meetings of a Committee established under this Division are to be held at the times and places that the chairperson of the Committee directs.
(2) At a meeting of a Committee:
(a) in the case of the Therapeutic Goods Committee -- 5 members constitute a quorum; and
(b) in the case of the Australian Drug Evaluation Committee -- 6 members, of whom at least 3 are core members, constitute a quorum; and
(c) in the case of the Medical Devices Evaluation Committee -- 6 members, of whom at least 4 are core members, constitute a quorum.
(2A) An associate member of the Australian Drug Evaluation Committee, or the Medical Devices Evaluation Committee, is eligible to attend a meeting of the relevant Committee only at the invitation of the chairperson of that Committee.
(2B) The Australian Drug Evaluation Committee may delegate to the chairperson of the Committee any function of the Committee.
(2C) The Medical Devices Evaluation Committee may delegate to the chairperson of the Committee any function of the Committee.
(3) The chairperson of a Committee is to preside at all meetings of the Committee at which he or she is present.
(4) If the chairperson of a Committee is absent from a meeting of a Committee, the members of the Committee present are to appoint one of their number to preside at that meeting.
(5) A question arising at a meeting of a Committee is to be determined by a majority of votes of the members present and voting.
(6) The member presiding at a meeting of a Committee has a deliberative vote and, in the event of an equality of votes, also has a casting vote.